15 August 2026
Latham Represents Zentalis Pharmaceuticals in US$80.5 Million Underwritten Public Offering
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Salvatore Vanchieri Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Rachel Moore | Latham & Watkins LLP | Associate | corporate | Not stated |
| Kan Ni | Latham & Watkins LLP | Associate | corporate | Not stated |
| Olivia Wagner | Latham & Watkins LLP | Associate | corporate | Not stated |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 80.5m (US$80.5 million)
- What the figure measures
- Issue size
- Client
- Zentalis Pharmaceuticals, Inc.Issuer
- Counterparties
- underwriters (Underwriters)